Jie Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jie Xu has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Francis Gosselin
Department of Synthetic Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
8 shared publications - Haiming Zhang
Department of Synthetic Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
5 shared publications - Lauren E. Sirois
Department of Synthetic Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
5 shared publications - Kyle Clagg
Department of Small Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
4 shared publications - Ngiap-Kie Lim
Department of Small Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States
4 shared publications - Cheol K. Chung
Department of Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
3 shared publications
Latest Publications
- 15 November 2023
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (6) , 2196-2202
Balancing Yield, Purity, and Form: Finding the Sweet Spot for the Rework of the First Clinical Batch of Giredestrant (GDC-9545)
- 15 November 2023
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (6) , 2196-2202
Balancing Yield, Purity, and Form: Finding the Sweet Spot for the Rework of the First Clinical Batch of Giredestrant (GDC-9545)
- 10 May 2023
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 25 (19) , 3417-3422
Second-Generation Atroposelective Synthesis of KRAS G12C Covalent Inhibitor GDC-6036
A chromatography-free asymmetric synthesis of GDC-6036 (1) was achieved via a highly atroposelective Negishi coupling of aminopyridine 5 and quinazoline 6b catalyzed by 0.5 mol % [Pd(cin)Cl]2 and 1 mol % (R,R)-Chiraphite to afford the key intermediate (Ra)-3. An alkoxylation of (Ra)-3 with (S)-N-methylprolinol (4) and a global deprotection generates the penultimate heterobiaryl intermediate 2. A controlled acrylamide installation by stepwise acylation/sulfone elimination and final adipate salt formation and crystallization delivered high-purity GDC-6036 (1).
- 10 May 2023
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 25 (19) , 3417-3422
Second-Generation Atroposelective Synthesis of KRAS G12C Covalent Inhibitor GDC-6036
A chromatography-free asymmetric synthesis of GDC-6036 (1) was achieved via a highly atroposelective Negishi coupling of aminopyridine 5 and quinazoline 6b catalyzed by 0.5 mol % [Pd(cin)Cl]2 and 1 mol % (R,R)-Chiraphite to afford the key intermediate (Ra)-3. An alkoxylation of (Ra)-3 with (S)-N-methylprolinol (4) and a global deprotection generates the penultimate heterobiaryl intermediate 2. A controlled acrylamide installation by stepwise acylation/sulfone elimination and final adipate salt formation and crystallization delivered high-purity GDC-6036 (1).
- 3 November 2022
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 144 (45) , 20955-20963
Atroposelective Negishi Coupling Optimization Guided by Multivariate Linear Regression Analysis: Asymmetric Synthesis of KRAS G12C Covalent Inhibitor GDC-6036
An efficient asymmetric synthesis of a potent KRAS G12C covalent inhibitor, GDC-6036 (1), is reported. The synthesis features a highly atroposelective Negishi coupling to construct the key C-C bond between two highly functionalized pyridine and quinazoline moieties by employing a Pd/Walphos catalytic system. Statistical modeling by comparing computational descriptors of a range of Walphos chiral bisphosphine ligands to a training set of experimental results was used to inform the selection of the best ligand, W057-2, which afforded the desired Negishi coupling product (Ra)-3 in excellent selectivity. A subsequent telescoped reaction sequence of alkoxylation, global deprotection, and acrylamide formation, followed by a final adipate salt formation, furnished GDC-6036 (1) in 40% overall yield from starting materials pyridine 5 and quinazoline 6.
- 3 November 2022
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 144 (45) , 20955-20963
Atroposelective Negishi Coupling Optimization Guided by Multivariate Linear Regression Analysis: Asymmetric Synthesis of KRAS G12C Covalent Inhibitor GDC-6036
An efficient asymmetric synthesis of a potent KRAS G12C covalent inhibitor, GDC-6036 (1), is reported. The synthesis features a highly atroposelective Negishi coupling to construct the key C-C bond between two highly functionalized pyridine and quinazoline moieties by employing a Pd/Walphos catalytic system. Statistical modeling by comparing computational descriptors of a range of Walphos chiral bisphosphine ligands to a training set of experimental results was used to inform the selection of the best ligand, W057-2, which afforded the desired Negishi coupling product (Ra)-3 in excellent selectivity. A subsequent telescoped reaction sequence of alkoxylation, global deprotection, and acrylamide formation, followed by a final adipate salt formation, furnished GDC-6036 (1) in 40% overall yield from starting materials pyridine 5 and quinazoline 6.
- 23 March 2022
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 87 (7) , 4955-4960
Stereoselective Synthesis of the IDO Inhibitor Navoximod
A highly efficient asymmetric synthesis of the IDO inhibitor navoximod, featuring the stereoselective installation of two relative and two absolute stereocenters from an advanced racemic intermediate, is described. The stereocenters were set via a crystallization-induced dynamic resolution along with two selective ketone reductions: one via a biocatalytic ketoreductase transformation and one via substrate-controlled hydride delivery from LiAlH(Ot-Bu)3. Following this strategy, navoximod was synthesized in 10 steps from 2-fluorobenzaldehyde and isolated in 23% overall yield with 99.7% ee and high purity.
- 23 March 2022
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 87 (7) , 4955-4960
Stereoselective Synthesis of the IDO Inhibitor Navoximod
A highly efficient asymmetric synthesis of the IDO inhibitor navoximod, featuring the stereoselective installation of two relative and two absolute stereocenters from an advanced racemic intermediate, is described. The stereocenters were set via a crystallization-induced dynamic resolution along with two selective ketone reductions: one via a biocatalytic ketoreductase transformation and one via substrate-controlled hydride delivery from LiAlH(Ot-Bu)3. Following this strategy, navoximod was synthesized in 10 steps from 2-fluorobenzaldehyde and isolated in 23% overall yield with 99.7% ee and high purity.
- 9 November 2021
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 26 (3) , 568-582
Efficient Manufacturing Process for the Selective Estrogen Receptor Degrader GDC-9545 (Giredestrant) via a Crystallization-Driven Diastereoselective Pictet–Spengler Condensation
- 9 November 2021
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 26 (3) , 568-582
Efficient Manufacturing Process for the Selective Estrogen Receptor Degrader GDC-9545 (Giredestrant) via a Crystallization-Driven Diastereoselective Pictet–Spengler Condensation
- 5 November 2021
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 26 (3) , 560-567
First-Generation Asymmetric Synthesis of the Selective Estrogen Receptor Degrader GDC-9545 (Giredestrant) Featuring a Highly Efficient Pictet–Spengler Reaction and a C–N Coupling Reaction
- 5 November 2021
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 26 (3) , 560-567
First-Generation Asymmetric Synthesis of the Selective Estrogen Receptor Degrader GDC-9545 (Giredestrant) Featuring a Highly Efficient Pictet–Spengler Reaction and a C–N Coupling Reaction
- 1 October 2020
- Published by Elsevier in Tetrahedron Letters
- Vol. 61 (43)
Fit-for-purpose synthesis of dual leucine zipper kinase (DLK) inhibitor GNE-834
- 1 October 2020
- Published by Elsevier in Tetrahedron Letters
- Vol. 61 (43)
Fit-for-purpose synthesis of dual leucine zipper kinase (DLK) inhibitor GNE-834
- 30 March 2020
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 24 (4) , 567-578
Process Development Overcomes a Challenging Pd-Catalyzed C–N Coupling for the Synthesis of RORc Inhibitor GDC-0022
- 30 March 2020
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 24 (4) , 567-578
Process Development Overcomes a Challenging Pd-Catalyzed C–N Coupling for the Synthesis of RORc Inhibitor GDC-0022
- 21 August 2018
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 20 (17) , 5431-5434
Synthesis of Chiral Tryptamines via a Regioselective Indole Alkylation
A practical synthesis of chiral tryptamines from simple, unprotected indoles has been developed. Indole nucleophiles prepared with MeMgCl in the presence of CuCl reacted with chiral cyclic sulfamidates almost exclusively at the C3-position of indole to form a variety of α- and/or β-substituted chiral tryptamines in good yield with excellent regioselectivity. The utility of this simple alkylation process has been demonstrated with the practical synthesis of two biologically active targets, cipargamin and TIK-301, which were completed in three steps, starting from the corresponding indole starting materials.
- 21 August 2018
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 20 (17) , 5431-5434
Synthesis of Chiral Tryptamines via a Regioselective Indole Alkylation
A practical synthesis of chiral tryptamines from simple, unprotected indoles has been developed. Indole nucleophiles prepared with MeMgCl in the presence of CuCl reacted with chiral cyclic sulfamidates almost exclusively at the C3-position of indole to form a variety of α- and/or β-substituted chiral tryptamines in good yield with excellent regioselectivity. The utility of this simple alkylation process has been demonstrated with the practical synthesis of two biologically active targets, cipargamin and TIK-301, which were completed in three steps, starting from the corresponding indole starting materials.
- 1 June 2018
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 22 (6) , 728-735
Practical Synthesis of a 6-Triazolylazabicyclo[3.1.0]hexane
- 1 June 2018
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 22 (6) , 728-735
Practical Synthesis of a 6-Triazolylazabicyclo[3.1.0]hexane